The evaluation of cystatin C, IL-Iβ, and TNF-α levels in total saliva and gingival crevicular fluid from 11- to 16-year-old children

Journal of Periodontology

Volumn 79, Issue 5, 2008, Pages 854-860

  Ülker, A Evren ^a   Tulunoglu, Özlem ^a   Özmeric, Nurdan ^a   Can, Murat ^b   Demirtas, Selda ^c  

^a GAZI UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c UFUK UNIVERSITY   (Turkey)

Author keywords

Children; Cystatin C; Gingival crevicular fluid; Interleukin 1 beta; Saliva; Tumor necrosis factor alpha

Indexed keywords

CYSTATIN; CYSTATIN C; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHILD; DENTITION; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PERIODONTICS; REFERENCE VALUE; SALIVA;

ADOLESCENT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CYSTATINS; DENTITION, PERMANENT; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; INTERLEUKIN-1BETA; MALE; PERIODONTAL INDEX; REFERENCE VALUES; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44349106982     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070422     Document Type: Article

References (44)

1. Heasman PA, Waterhouse PJ. Periodontal disease in children. In: Welbury RR, Duggal MS, Hosey MT, eds. Paediatric Dentistry. Oxford, U.K.: Oxford University Press; 2005:231-256.
2. Califano JV. Periodontal diseases of children and adolescents. Pediatr Dent 2005;27:189-196.
3. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
4. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003;31:167-180.
5. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
6. Bascones A, Gamonal J, Gomez M, Silva A, Gonzalez MA. New knowledge of the pathogenesis of periodontal disease. Quintessence Int 2004;35:706-716.
7. Dickinson DP. Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002;13:238-275.
8. Bobek LA, Levine MJ. Cystatins - Inhibitors of cysteine proteinases. Crit Rev Oral Biol Med 1992;3:307-332.
9. Turk V, Bode W. The cystatins: Protein inhibitors of cysteine proteinases. FEBS Lett 1991;285:213-219.
10. Lupi A, Messana I, Denotti G, et al. Identification of the human salivary cystatin complex by the coupling of high-performance liquid chromatography and ion-trap mass spectrometry. Proteomics 2003;3:461-467.
11. Henskens YM, Veerman EC, Mantel MS, van der Velden U, Nieuw Amerongen AV. Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res 1994;73:1606-1614.
12. Blankenvoorde MF, Henskens YM, van der Weijden GA, van den Keijbus PA, Veerman EC, Nieuw Amerongen AV. Cystatin A in gingival crevicular fluid of periodontal patients. J Periodontal Res 1997;32:583-588.
13. Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid levels of interleukin-1 beta, leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res 1993;28:241-247.
14. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
15. Preiss DS, Meyle J. Interleukin-1 beta concentration of gingival crevicular fluid. J Periodontol 1994;65:423-428.
16. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
17. Yavuzyilmaz E, Yamalik N, Bulut S, Ozen S, Ersoy F, Saatci U. The gingival crevicular fluid interleukin-1 beta and tumour necrosis factor-alpha levels in patients with rapidly progressive periodontitis. Aust Dent J 1995;40:46-49.
18. Kurtis B, Tuter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005;76:1849-1855.
19. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
20. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
21. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991;62:504-509.
22. Henskens YM, van der Velden U, Veerman EC, Nieuw Amerongen AV. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J Periodontal Res 1993;28:43-48.
23. Henskens YM, van den Keijbus PA, Veerman EC, et al. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J Periodontal Res 1996;31:57-65.
24. Aguirre A, Testa-Weintraub LA, Banderas JA, Dunford R, Levine MJ. Levels of salivary cystatins in periodontally healthy and diseased older adults. Arch Oral Biol 1992;37:355-361.
25. Baron AC, Gansky SA, Ryder MI, Featherstone JD. Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients. J Periodontal Res 1999;34:437-444.
26. Henskens YM, van der Weijden FA, van den Keijbus PA, et al. Effect of periodontal treatment on the protein composition of whole and parotid saliva. J Periodontol 1996;67:205-212.
27. Lie MA, Loos BG, Henskens YM, et al. Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers. J Clin Periodontol 2001;28:979-984.
28. van Gils PC, Brand HS, Timmerman MF, Veerman EC, van der Velden U, van der Weijden GA. Salivary cystatin activity and cystatin C in experimental gingivitis in nonsmokers. J Clin Periodontol 2003;30:882-886.
29. Skaleric U, Babnik J, Curin V, Lah T, Turk V. Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva. Arch Oral Biol 1989;34:301-305.
30. Lah TT, Babnik J, Schiffmann E, Turk V, Skaleric U. Cysteine proteinases and inhibitors in inflammation: Their role in periodontal disease. J Periodontol 1993;64:485-491.
31. Lerner UH, Modeer T, Krekmanova L, Claesson R, Rasmussen L. Gingival crevicular fluid from patients with periodontitis contains bone resorbing activity. Eur J Oral Sci 1998;106:778-787.
32. Yucel-Lindberg T, Nilsson S, Modeer T. Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1 beta and tumor necrosis factor alpha in human gingival fibroblasts. J Dent Res 1999;78:61-68.
33. Yakovlev E, Kalichman I, Pisanti S, Shoshan S, Barak V. Levels of cytokines and collagen type 1 and type III as a function of age in human gingivitis. J Periodontol 1996;67:788-793.
34. Ullbro C, Crossner CG, Nederfors T, et al. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome. Acta Odontol Scand 2004;62:70-74.
35. McFarlane CG, Reynolds JJ, Meikle MC. The release of interleukin-1 beta, tumor necrosis factor-alpha and interferon-gamma by cultured peripheral blood mononuclear cells from patients with periodontitis. J Periodontal Res 1990;25:207-214.
36. Miller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross-sectional study. J Am Dent Assoc 2006;137:322-329.
37. Wozniak KL, Arribas A, Leigh JE, Fidel PL Jr. Inhibitory effects of whole and parotid saliva on immunomodulators. Oral Microbiol Immunol 2002;17:100-107.
38. Rossomando EF, Kennedy JE, Hadjimichael J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990;35:431-434.
39. Faizuddin M, Bharathi SH, Rohini NV. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res 2003;38:111-114.
40. Page RC, Beck JD. Risk assessment for periodontal diseases, Int Dent J 1997;47:61-87.
41. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
42. Haffajee AD, Socransky SS, Dzink JL, Taubman MA, Ebersole JL, Smith DJ. Clinical, microbiological and immunological features of subjects with destructive periodontal diseases. J Clin Periodontol 1988;15:240-246.
43. Fine DH, Mandel ID. Indicators of periodontal disease activity: An evaluation. J Clin Periodontol 1986;13:533-546.
44. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K. Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factoralpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999;44:535-539.